Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands

• DOI: 10.3201/eid2611.202736
• Publication Date: 2020-07-29T16:12:17Z
• Authors: Maria Skaalum Pet...; Marin Strøm; Debes Hammershaim...; Jógvan Páll Fjall...; Eina Hansen Eliasen; Malan Johansen; Anna Sofía Veyhe; Marnar Fríðheim K...; Shahin Gaini; Lars Fodgaard Møller; Bjarni Steig; Pál Weihe
• Keywords: Adult; Male; Denmark; Pneumonia, Viral; Infectious and parasitic diseases; RC109-216; Antibodies, Viral; 2019 novel coronavirus disease; Betacoronavirus; Young Adult; 03 medical and health sciences; COVID-19 Testing; 0302 clinical medicine; Seroepidemiologic Studies; Research Letter; Humans; Pandemics; respiratory diseases; Clinical Laboratory Techniques; SARS-CoV-2; R; COVID-19; 3. Good health; coronavirus disease; Medicine; Female; Coronavirus Infections; severe acute respiratory syndrome coronavirus 2

We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.